Get Integrated Data for Your Specialty and Interest Aresa
 
Category Select :
Items 101 ~ 120 of 25944, Page 6 of 1298
101. Statement on steps toward a new, tailored review framework for artificial intelligence-based medical devices - 04/02/2019
 U.S. FOOD & DRUG ADMINISTRATION
102. Bariatric Embolization Shows Promise in Treatment of Obesity - 04/02/2019
 Radiological Society of North America
  Bariatric embolization, a new, minimally invasive treatment for obesity produces weight loss and reduces appetite for up to one year, according to a new study published in the journal Radiology.
103. Older Women Benefit Significantly When Screened with 3-D Mammography - 04/02/2019
 Radiological Society of North America
  Mammography remains an effective method for breast cancer screening in women ages 65 and older, with the addition of a 3-D technique called tomosynthesis improving screening performances even more, according to a study published in the journal Radiology.
104. Statement from FDA Commissioner Scott Gottlieb, M.D., on the agencys continued efforts to bring competition to the insulin market to lower prices and expand access - 04/02/2019
 U.S. FOOD & DRUG ADMINISTRATION
105. FDA takes new enforcement actions as part of the agencys ongoing effort to combat the illegal online sales of opioids - 04/02/2019
 U.S. FOOD & DRUG ADMINISTRATION
106. Statement on new steps to advance agencys continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products - 04/02/2019
 U.S. FOOD & DRUG ADMINISTRATION
107. Merck Completes Tender Offer to Acquire Immune Design - 04/02/2019
 MERCK
108. USDA, EPA, and FDA Recognize April as Winning on Reducing Food Waste Month - 04/02/2019
 U.S. FOOD & DRUG ADMINISTRATION
109. Merck to Hold First-Quarter 2019 Sales and Earnings Conference Call on April 30 - 04/02/2019
 MERCK
110. Selumetinib Granted U.S. Breakthrough Therapy Designation in Neurofibromatosis Type 1 - 04/01/2019
 MERCK
  Designation Based on Phase 2 SPRINT Trial in Pediatric Patients with NF1 Plexiform Neurofibromas / Selumetinib Is a MEK 1/2 Inhibitor Being Co-Developed by AstraZeneca and Merck
111. Merck Completes Acquisition of Antelliq Corporation to Become Leader in Emerging Digital Technology for Livestock and Companion Animals - 04/01/2019
 MERCK
112. Statement on new efforts to advance treatment strategies for helping youth addicted to nicotine as a result of the epidemic rise in teen use of e-cigarettes - 04/01/2019
 U.S. FOOD & DRUG ADMINISTRATION
113. FDA warns homeopathic firms for putting patients at risk with significant violations of manufacturing quality standards - 04/01/2019
 U.S. FOOD & DRUG ADMINISTRATION
114. Mercks KEYTRUDA (pembrolizumab) Approved in China for First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer (NSCLC) in Combination with Chemotherapy - 04/01/2019
 MERCK
  KEYTRUDA is First Anti-PD-1 Therapy to be Approved in Multiple Tumor Types in China
115. Data for Mercks KEYTRUDA (pembrolizumab) Across Different Types of Advanced Lung Cancer Presented at AACR Annual Meeting 2019 - 04/01/2019
 MERCK
  First Presentation of Overall Survival Data from Post-Hoc Analysis of KEYNOTE-189 in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Who Have Liver or Brain Metastases / Pooled Data in Patients with Previously Treated Advanced Small Cell Lung Cancer in AACR 2019 Plenary Session and Press Conference
116. FDA approves new oral treatment for multiple sclerosis - 03/29/2019
 U.S. FOOD & DRUG ADMINISTRATION
117. Statement by FDA Commissioner Scott Gottlieb, M.D., Director of FDAs Center for Drug Evaluation and Research Janet Woodcock, M.D. and Director of FDAs Center for Biologics Evaluation and Research Peter Marks, M.D. on Expanded Access ?Looking Forward - 03/29/2019
 U.S. FOOD & DRUG ADMINISTRATION
118. FDA approves treatment for patients with a type of inflammatory arthritis - 03/28/2019
 U.S. FOOD & DRUG ADMINISTRATION
119. Statement on actions to advance our comprehensive plan to reduce tobacco-related disease and death, through new efforts to improve the tobacco product application review process, including a newly proposed rule - 03/28/2019
 U.S. FOOD & DRUG ADMINISTRATION
120. Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for testimony before a U.S. Senate Subcommittee on Appropriations on FDAs Fiscal Year 2020 budget - 03/28/2019
 U.S. FOOD & DRUG ADMINISTRATION
<<  <  [1]  [2]  [3]  [4]  [5]  [6[7]  [8]  [9]  [10]  >  >>
 


Copyright ~2018 by Medisurf. All Rights Reserved Terms of Service Privacy Email : medalls@medalls.com